Jordan M. Valone

Jordan M. Valone

Auto-generated profile, based on publicly available information

Jordan M. Valone

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
NMNana Matoba
Nana Matoba
BLBrandon D. Le
Brandon D. Le
JVJordan M. Valone
Jordan M. Valone
JWJustin M. Wolter
Justin M. Wolter
JMJessica T. Mory
Jessica T. Mory
JSJason L. Stein
Jason L. Stein

23 September 2026 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
NMNana Matoba
Nana Matoba
JMJessica C. McAfee
Jessica C. McAfee
OKOleh Krupa
Oleh Krupa
ABAlvaro A. Beltran
Alvaro A. Beltran
JBJessica L. Bell
Jessica L. Bell
JSJason L. Stein
Jason L. Stein
Genetic association studies have identified hundreds of largely noncoding loci associated with interindividual differences in the structure of the human cortex, although the specific functional variants contributing to these phenotypes are unknown. Here we implemented a massively parallel reporter assay to measure the regulatory activity of 9,092 cortical-structure-associated variants in human neural progenitor cells at baseline and during Wnt stimulation. We identified 918 variants with regulatory potential from 150 cortical-structure-associated loci (76% of loci studied), of which more than 50% showed allelic effects. Wnt stimulation modified regulatory activity at a subset of loci, revealing condition-dependent enhancers. Massively parallel reporter assay activity was largely induced by Alu elements, suggesting that they contribute to cortical expansion. The region-specific impact of motif-disrupting variants is probably mediated by spatially localized transcription factor expression during development. Together, these results provide a genome-scale functional framework for understanding how noncoding variation influences cortical structure.

14 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JVJordan M Valone
Jordan M Valone
BLBrandon D Le
Brandon D Le
NMNana Matoba
Nana Matoba
JMJessica T Mory
Jessica T Mory
JWJustin M Wolter
Justin M Wolter
JSJason L Stein
Jason L Stein
Gene by treatment (GxT) interactions likely contribute to variability in clinical response, but are difficult to identify in population studies. Here, we applied psychiatric and neurological disorder treatments to a genotyped population of human neural progenitors (n=83 donors) and measured molecular responses on chromatin accessibility and gene expression. Gene regulatory responses to valproic acid (VPA), which is also a prenatal risk factor for autism, and lithium were highly enriched in genetic risk for psychiatric disorders, demonstrating the convergence of environmental and genetic factors. Genetic variation impacted molecular response to these drugs at over 1,000 loci, a subset of which modulated the impacts of psychiatric disorder risk variants. Finally, transcriptome-wide association revealed enzymes involved with folate metabolism during VPA exposure impact cognitive ability, a pathway previously shown to alleviate the negative impacts of this exposure. The “GxT in a dish” approach identified a validated treatment pathway, supporting its broad utility.

4 April 2026 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
JVJordan M. Valone
Jordan M. Valone
BLBrandon D. Le
Brandon D. Le
NMNana Matoba
Nana Matoba
JMJessica T. Mory
Jessica T. Mory
JWJustin M. Wolter
Justin M. Wolter
JSJason L. Stein
Jason L. Stein
Gene by treatment (GxT) interactions likely contribute to variability in clinical response, but are difficult to identify in population studies. Here, we applied psychiatric and neurological disorder treatments to a genotyped population of human neural progenitors (n = 83 donors) and measured molecular responses on chromatin accessibility and gene expression. Gene regulatory responses to valproic acid (VPA), which is also a prenatal risk factor for autism, and lithium were highly enriched in genetic risk for psychiatric disorders, demonstrating the convergence of environmental and genetic factors. Genetic variation impacted molecular response to these drugs at over 1000 loci, a subset of which modulated the impacts of psychiatric risk variants. Finally, transcriptome-wide association conducted in the context of VPA revealed genes involved with folate metabolism associated with cognitive ability. As previous work has shown that folate supplementation can alleviate VPA-induced teratogenic effects, this approach identified a validated treatment pathway supporting its broad utility.

6 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
YHYuriko Harigaya
Yuriko Harigaya
NMNana Matoba
Nana Matoba
BLBrandon D. Le
Brandon D. Le
JVJordan M. Valone
Jordan M. Valone
JSJason L. Stein
Jason L. Stein
WVWilliam Valdar
William Valdar
Genetic variation can modulate response to treatment (G×T) or environmental stimuli (G×E), both of which may be highly consequential in biomedicine. An effective approach to identifying G×T signals and gaining insight into molecular mechanisms is mapping quantitative trait loci (QTL) of molecular count phenotypes, such as gene expression and chromatin accessibility, under multiple treatment conditions, which is termed response molecular QTL mapping. Although standard approaches evaluate the interaction between genetics and treatment conditions, they do not distinguish between meaningful interpretations such as whether a genetic effect is only observed in the treated condition or whether a genetic effect is observed but accentuated in the treated condition. To address this gap, we have developed a downstream method for classifying response molecular QTLs into subclasses with meaningful genetic interpretations. Our method uses Bayesian model selection and assigns posterior probabilities to different types of G×T interactions for a given feature-SNP pair. We compare linear and nonlinear regression of log-scale counts, noting that the latter accounts for an expected biological relationship between the genotype and the molecular count phenotype. Through simulation and application to existing datasets of molecular response QTLs, we show that our method provides an intuitive and well-powered framework to report and interpret G×T interactions. We provide a software package, ClassifyGxT, which is available at https://github.com/yharigaya/classifygxt . Author summary: Responses to treatment, such as drug, therapeutic intervention, and infection, can vary across individuals at least in part due to their genetic backgrounds. This phenomenon can be conceptualized as a manifestation of gene-by-treatment (G×T) or gene-by-environment (G×E) interactions, which refer to non-additive effects of genotype and treatment on traits and phenotypes. An understading of G×T or G×E interactions can potentially improve strategies for prevention and treatment of diseases, for example by selecting treatments for which a patient is most likely to respond given their genetic information, or enhanced screening for individuals most susceptible to environmental exposures. An effective approach to G×T discovery is response quantitative trait loci (QTL) mapping, where the effect of the treatment on the association between the genotype and phenotype is examined using a linear regression model including the genotype, treatment, and G×T interaction terms. Despite its effectiveness in identifying a large number of associations, the response QTL mapping relies on hypothesis testing, which does not provide classification of different types of G×T interactions. Herein, we propose a use of Bayesian model selection to classify the G×T types of response QTLs and provide a software package for this method. In addition to standard linear regression, our package provides an option to use nonlinear regression that is suited for molecular count phenotypes, such as gene expression and chromatin accessibility, measured by sequencing-based techniques. It also provides an option to use mixed effect models to accommodate replicate measurements per donor, which are common in data generated in in-vitro cell systems.